Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 25, 2012 - Issue 6
Submit an article Journal homepage
63
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Adding ADAM12 in risk calculation program does not improve the detection rate of trisomies 18 and 13 in first trimester screening

Yrtti ValinenDepartment of Obstetrics and Gynecology, Oulu University Hospital, Finland
,
Jaana MarttalaDepartment of Obstetrics and Gynecology, Oulu University Hospital, Finland
,
Maarit SahravandDepartment of Obstetrics and Gynecology, Oulu University Hospital, Finland
,
Ilkka JarvelaDepartment of Obstetrics and Gynecology, Oulu University Hospital, Finland
,
Timppa HonkasaloDepartment of Obstetrics and Gynecology, Oulu University Hospital, Finland
,
Paivi LaitinenLaboratory of Clinical Chemistry, HUSLAB, Helsinki University Hospital, Finland
&
Markku RyynanenDepartment of Obstetrics and Gynecology, Oulu University Hospital, FinlandCorrespondence[email protected]
 show all
Pages 822-825 | Received 25 Feb 2011, Accepted 17 May 2011, Published online: 06 Feb 2012

References

  • Hook EB, Cross PK, Schreinemachers DM. Chromosomal abnormality rates at amniocentesis and in live-born infants. JAMA 1983;249:2034–2038.
  • Snijders RJ, Sebire NJ, Nicolaides KH. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 1995;10:356–367.
  • Marttala J, Yliniemi O, Gissler M, Nieminen P, Ryynanen M. Prevalence of Down’s syndrome in a pregnant population in Finland. Acta Obstet Gynecol Scand 2010;89:715–717.
  • Marttala J, Peuhkurinen S, Ranta JK, Laitinen P, Kokkonen HL, Honkasalo T, Ryynanen M. Screening and outcome of chromosomal abnormalities other than trisomy 21 in Northern Finland. Acta Obstet Gynecol Scand 2010; submitted.
  • Shaw J. Trisomy 18: a case study. Neonatal Netw 2008;27:33–41.
  • de Grouchy J, Turtleau C. Clinical atlas of human chromosomes. New York: John Wiley & Sons;1984.
  • Wewer UM, Albrechtsen R, Engvall E. ADAM12: The long and the short of it. In: Hooper NM, Lendeckel U, Eds. The ADAM family of proteases. 4th ed. London (UK): Kluwer Academic/Springer; 2005.
  • Laigaard J, Sørensen T, Fröhlich C, Pedersen BN, Christiansen M, Schiøtt K, Uldbjerg N, et al. ADAM12: a novel first-trimester maternal serum marker for Down syndrome. Prenat Diagn 2003;23:1086–1091.
  • Laigaard J, Christiansen M, Fröhlich C, Pedersen BN, Ottesen B, Wewer UM. The level of ADAM12-S in maternal serum is an early first-trimester marker of fetal trisomy 18. Prenat Diagn 2005;25:45–46.
  • Laigaard J, Sørensen T, Placing S, Holck P, Fröhlich C, Wøjdemann KR, Sundberg K, et al. Reduction of the disintegrin and metalloprotease ADAM12 in preeclampsia. Obstet Gynecol 2005;106:144–149.
  • Spencer K, Cowans NJ. ADAM12 as a marker of trisomy 18 in the first and second trimester of pregnancy. J Matern Fetal Neonatal Med 2007;20:645–650.
  • Spencer K, Cowans NJ, Stamatopoulou A. Maternal serum ADAM12s as a marker of rare aneuploidies in the first or second trimester of pregnancy. Prenat Diagn 2007;27:1233–1237.
  • Reynolds TM, Penney MD. The mathematical basis of multivariate risk screening: with special reference to screening for Down’s syndrome associated pregnancy. Ann Clin Biochem 1990;27 (Pt 5):452–458.
  • Wald NJ, Hackshaw AK. Combining ultrasound and biochemistry in first-trimester screening for Down’s syndrome. Prenat Diagn 1997;17:821–829.
  • Cuckle HS, van Lith JM. Appropriate biochemical parameters in first-trimester screening for Down syndrome. Prenat Diagn 1999;19:505–512.
  • Tsukerman GL, Gusina NB, Cuckle HS. Maternal serum screening for Down syndrome in the first trimester: experience from Belarus. Prenat Diagn 1999;19:499–504.
  • Valinen Y, Laitinen P, Ranta J, Ignatius J, Jarvela I, Ryynänen M. Effect of a new marker, ADAM12, on Down risk figures in first trimester screening. J Matern Fetal Neonatal Med 2009;22:602–607.
  • Poon LC, Chelemen T, Minekawa R, Frisova V, Nicolaides KH. Maternal serum ADAM12 (A disintegrin and metalloprotease) in chromosomally abnormal pregnancy at 11-13 weeks. Am J Obstet Gynecol 2009;200:508.e1–508.e6.
  • Valinen Y, Peuhkurinen S, Järvelä IY, Laitinen P, Ryynanen M. Maternal serum ADAM12 levels correlate with PAPP-A levels during the first trimester. Gynecol Obstet Invest 2010;70:60–63.
  • Laigaard J, Spencer K, Christiansen M, Cowans NJ, Larsen SO, Pedersen BN, Wewer UM. ADAM 12 as a first-trimester maternal serum marker in screening for Down syndrome. Prenat Diagn 2006;26:973–979.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.